For several GPCRs, discrimination between agonism and antagonism is possible on the basis of thermodynamics parameters, such as binding enthalpy and entropy. In this study, we analyze whether agonists and antagonists can also be discriminated thermodynamically at the histamine H 1 receptor (H 1 R). Because previous studies revealed species differences in pharmacology between human H 1 R (hH 1 R) and guinea pig H 1 R (gpH 1 R), we analyzed a broad spectrum of H 1 R antagonists and agonists at hH 1 R and gpH 1 R. [
two different orientations. Our studies revealed significant species differences in binding enthalpy and entropy between hH 1 R and gpH 1 R for some antagonists and agonists. Furthermore, in some cases, we found changes in heat capacity of the binding process that were different from zero. Differences in flexibility of the ligands may be responsible for this observation. For most ligands, the binding process to hH 1 R and gpH 1 R is clearly entropy-driven. In contrast, for the endogenous ligand histamine, the binding process is significantly enthalpy-driven at both species isoforms. Thus, a definite discrimination between antagonism and agonism based on thermodynamic parameters is possible for neither hH 1 R nor gpH 1 R, but thermodynamic analysis of ligand-binding may be a novel approach to dissect agonist-and antagonist-specific receptor conformations.
The histamine H 1 -receptor (H 1 R) is a biogenic amine receptor that belongs to the G-protein-coupled receptors (GPCRs) and couples to G q -proteins (Hill et al., 1997) . H 1 R antagonists ( Fig. 1, 1-8 ) have relevance in treatment of allergic diseases. In contrast, H 1 R agonists (Fig. 1, 9-22 ) are used as tools to study the pharmacology and functionality of the H 1 R on a molecular level. Several classes of synthetic H 1 R agonists are known, including phenylhistamines Zingel et al., 1995) , histaprodifens (Elz et al., 2000; Menghin et al., 2003) , and phenoprodifens (Strasser et al., 2008b) . Weiland et al. (1979) were the first to find that antagonists and agonists can be thermodynamically discriminated at the ␤-adrenergic receptor. Subsequently, several radioligand binding studies at the cholecystokinin CCK 2 receptor (Harper et al., 2007b) , ␤-adrenergic receptor (Weiland et al., 1979; Contreras et al., 1986a,b) , serotonin 5-HT 1A -receptor , histamine H 3 receptor (Harper et al., 2007a) , dopamine D 2 receptor (Kilpatrick et al., 1986; Duarte et al., 1988) and adenosine A 1 and A 2A receptors were performed at different temperatures to determine thermodynamic parameters such as binding enthalpy (⌬H°) and binding entropy (⌬S°) of the ligand to the receptor. These studies showed that a thermodynamic discrimination between agonism and antagonism is only possible at some of the receptors (e.g., ␤-adrenergic receptor, 5-HT 3 , A 1 , and A 2A receptors). However, for some receptors, such as the D 2 (Kilpatrick et al., 1986; Duarte et al., 1988) and 5-HT 1A receptors, no thermodynamic discrimination between agonists and antagonists was found.
Previous studies from our laboratory Strasser et al., 2008) revealed substantial species differences in affinity between hH 1 R and gpH 1 R for some H 1 R agonists, such as suprahistaprodifen 19, phenoprodifen 20, and dimeric hi-staprodifen 22, and for the first-generation H 1 R antagonist mepyramine 1. Several mutational studies identified amino acids interacting with antagonists in the H 1 R binding pocket (Wieland et al., 1999) and amino acids responsible for species differences between hH 1 R and gpH 1 R (Bruysters et al., 2005; Strasser et al., 2008b) concerning agonists. Because there has been no thermodynamic study of ligand binding to the H 1 R, the aim of this study was to analyze the following questions: 1) Is there a thermodynamic discrimination between agonists and antagonists at hH 1 R and gpH 1 R? 2) Are there species differences in ⌬H°and ⌬S°between hH 1 R and gpH 1 R?
To answer those two questions, we coexpressed hH 1 R or gpH 1 R with the regulator of G-protein signaling RGS4 in Sf9 insect cells and characterized a broad spectrum of H 1 R agonists, such as phenylhistamines, histaprodifens, and phenoprodifens, as well as H 1 R antagonists, such as flexible and tricylic antagonists in [ 3 H]mepyramine competition binding assays at five different temperatures in a temperature range from 283.15 to 303.15 K. In addition, we did not use the van't Hoff equation to determine the binding enthalpy and entropy, as is usually the case. Instead, we used a more general thermodynamic equation that also takes into account the possibility that binding enthalpy and entropy could be temperature-dependent.
Because we included ligands, such as suprahistaprodifen 19, phenoprodifen 20, and chiral phenoprodifens 21R and 21S, which are predicted to bind in two different orientations to the H 1 R (Strasser et al., 2008a (Strasser et al., , 2009 , we additionally performed a temperature-dependent 3D-QSAR analysis to predict thermodynamic properties for orientations 1 and 2.
Materials and Methods

Materials.
[ antagonists (1-8) and H 1 R agonists. 1, mepyramine; 2, diphenhydramine; 3, fexofenadine; 4, terfenadine; 5, amitriptyline; 6, mianserin; 7, clozapine; 8, chlorpromazine; 9, histamine; 10-12, phenylhistamines; 13-18, histaprodifens; 19, suprahistaprodifen; 20 and 21, phenoprodifens; and 22, dimeric histaprodifen. tillation cocktail was from Roth (Karlruhe, Germany). Compounds 1 to 8 were from Sigma (St. Louis, MO). Compound 14 was synthesized as described previously (Menghin, 2004) . Sources of all other materials were described previously Strasser et al., 2008a Strasser et al., ,b, 2009 .
Preparation of Compound Stock Solutions. All chemical structures of the analyzed compounds are given in Fig. 1 . Compounds 1, 2, 9, 10, 11R, and 11S (10 mM each) were dissolved in double-distilled water. Compounds 3 to 8 (1 mM each) and 12 (5 mM) were dissolved in a solvent containing 50% (v/v) DMSO and 50% (v/v) double-distilled water. Compounds 13 and 15 to 21 (5 mM each) were dissolved in a solvent containing 30% (v/v) DMSO, 30% (v/v) Tris/ HCl, pH 7.4 (10 mM), and 40% (v/v) double-distilled water. Compounds 14 and 22 (1 mM) were dissolved in 50% (v/v) DMSO and 50% (v/v) Tris/HCl, pH 7.4 (10 mM). The final DMSO concentration in all assays was adjusted to 3% (v/v) or 5% (v/v) as appropriate for a given compound.
Competition Binding Assays. The [ 3 H]mepyramine competition binding assays were performed as described previously (Strasser et al., 2008a) . The assays were carried out two to four times each at temperatures of 283.15, 288.15, 293.15, 298.15, and 303.15 K and, for some compounds, 308 .15 K. The temperature was held constant to Ϯ0.1°C, using a water thermostat. To guarantee equilibrium, we carried out preliminary experiments at different incubation times for all ligands at all temperatures. Based on these data, we determined incubation times of 4 h at 283.15 K, 3.5 h at 288.15 K, 1.5 h at 293.15 K and 298.15 K, and 1 h at 303.15 K to ensure equilibrium conditions.
Binding Mode of Dimeric Histaprodifen. Dimeric histaprodifen (22) in its bioactive conformation at hH 1 R and gpH 1 R, resulting from molecular dynamics simulations (Strasser et al., 2008b) , was used as template structure for the molecular alignment of all other ligands in the 3D-QSAR study: the quaternary amine moiety, located in the center of dimeric histaprodifen, establishes an electrostatic interaction to Asp 3.32 and Tyr 7.43 . One imidazole moiety forms stable hydrogen bonds to Ser 3.36 and Tyr 6.51 , and the second imidazole moiety forms stable hydrogen bonds to Glu190 (E2-loop) and Trp 7.40 . There were no differences in hydrogen bond networking of dimeric histaprodifen 22 with hH 1 R and gpH 1 R. Both diphenyl propyl moieties of 22 are embedded in hydrophobic pockets.
3D-QSAR. The 3D-QSAR calculations concerning histamine 9, phenylhistamines 10 to 12, histaprodifens 13 to 19 and 22, and phenoprodifens 20, 21R, and 21S were performed with the software package SYBYL (ver. 7.0; Tripos, St. Louis, MO) . In the training set we included all ligands with only one possible orientation in the binding pocket (i.e., compounds 9-18 and 22). In the test sets, we included all ligands with two possible orientations (i.e., compounds 19, 20, 21R, and 21S). The classification of the ligands in a group with one possible orientation and a group with two possible orientations is based on the following considerations: suprahistaprodifen 19 is a substructure of dimeric histaprodifen 22 and should therefore be able to bind in two different orientations. Dimeric phenylhistamine 12 and dimeric histaprodifen 22 bind to the H 1 R, and thus phenoprodifens 20, 21R, and 21S, containing a phenylhistamine and histaprodifen partial structure, should be able to bind in two different orientations into the binding-pocket of the H 1 R. Besides, both orientations of 20 led to stable ligand-receptor complexes in molecular dynamics simulations (Strasser et al., 2009 ). This considerations concerning symmetry of the ligands are not valid for ligands 15 to 18. Accordingly, these ligands are expected to bind in only one orientation. We used dimeric histaprodifen 22 in its bioactive conformation at hH 1 R and gpH 1 R, resulting of molecular dynamics simulations, as template structure for the molecular alignment of all other ligands (Strasser et al., 2008b) . All other ligands were constructed with SYBYL, except for histamine 9. Because the binding mode of histamine 9 differs from the binding mode of the histamine partial structures in phenylhistamines and histaprodifens, histamine was docked manually in its bioactive conformation as described previously to hH 1 R and gpH 1 R using SYBYL. All ligands have one positive charge on the amine moiety. For energetic calculations and minimizations, we used the Tripos-Force-Field and Gasteiger-Hü ckel partial charges. The alignment was performed with SYBYL using the MultiFit tool. All compounds that can bind in two different orientations in the binding-pocket were aligned in both orientations. This alignment was used for the subsequent comparative molecular field analysis study for each temperature at hH 1 R and gpH 1 R. The relationship between the ligand structure and the affinities was quantified by the partial least-square (PLS) algorithm (Wold et al., 1993) . The cross-validation analysis was performed using the leave-one-out method. In most cases of single 3D-QSAR studies at each temperature for hH 1 R and gpH 1 R, the cross-validated r 2 resulted in an optimum number of six components for lowest standard error of prediction. Thus, to obtain comparable results for each 3D-QSAR study, we used six components for the subsequent PLS analysis. The predicted pK i values were used to calculate the thermodynamic parameters ⌬H°(p,T o ), ⌬S°(p,T o ), and ⌬C p°a s described in the next paragraph.
Calculation of Thermodynamic Parameters. For the ligand receptor binding equilibrium L ϩ R ª LR (L ϭ ligand, R ϭ receptor, LR ϭ ligand-receptor-complex), the affinity constants are calculated as
Ligand-receptor binding at constant temperature T and pressure p is accompanied by a decrease of the Gibbs energy of the system, composed of the solvent, the free ligand, and membrane-bound receptor and ligand-receptor-complex, until equilibrium is reached. The resulting equilibrium constant for the association process K A is related to the change of Gibbs energy of reference state (infinite dilution for each reactant):
where R is the gas constant. The binding enthalpy ⌬H°and binding entropy ⌬S°are related to ⌬G°in the following way:
The binding enthalpy ⌬H°(p,T) and binding entropy ⌬S°(p,T) are related to enthalpies and entropies of ligand H L , S L , of receptor H R , S R and of ligand-receptor-complex H LR , S LR , respectively in the following way:
In the case of temperature-independent binding enthalpy and binding entropy change, these quantities can be calculated by using the van't Hoff equation:
In the case of temperature-dependent ⌬H°and ⌬S°, we used the following fundamental thermodynamic relations for calculation of these quantities:
and where ⌬C p°r epresents the change in the reference molar heat capacity of the given reaction. Considering this quantity to be temperature-independent as a first approximation, we yield the following relations for ⌬H°(p,T) and ⌬S°(p,T) by integration:
and
with the reference temperature T o ϭ 293.15 K. Using eqs. 3, 9, and 10, the following expression for ⌬G°(p,T) can be derived Miscellaneous. The generation of baculoviruses used was described previously Strasser et al., 2008) . Cell culture, membrane preparation and determination of protein concentration were performed as described previously (Kelley et al., 2001; Seifert et al., 2003; Strasser et al., 2008a) . For data analysis, the software Prism 4.02 (GraphPad Software, San Diego, CA) was used. pK i values were calculated according to Cheng and Prusoff (1973) . All pK i values are the means Ϯ S.E.M. of two to four independent experiments. For comparison of two pairs of data, the significance of the deviation of zero p was calculated using the t test.
Results
Ligand-and Receptor-Specific Differences in Temperature Dependence of pK i Values. The pK i values determined for hH 1 R and gpH 1 R at five temperatures in the range between 283.15 and 303.15 K (308.15 K for 1, 4, 5, and 7) are summarized in Table 1 and plotted in Fig. 2 . pK i values exhibited ligand-and receptor-specific differences in temperature dependence. The H 1 R antagonists 1 -8 showed high affinity to hH 1 R and gpH 1 R within the analyzed temperature range from 283.15 K to 303.15 (308.15 for 1, 4, 5 and 7). Mepyramine 1, diphenhydramine 2, and chlorpromazine 8 showed no significant temperature-dependence in affinity. However, some ligands showed a substantial temperaturedependence in affinity, such as fexofenadine 3, terfenadine 4, and clozapine 7. For clozapine 7 (Fig. 3) , the increase in affinity from 283.15 to 308.15 K was approximately 1 unit in pK i . Most of the ligands showed no species-dependent differences in temperature-dependence of affinities. Nonetheless, for the rigid tricyclic ligands amitriptyline 5, mianserin 6, and clozapine 7, the temperature dependence of pK i values was larger at gpH 1 R than at hH 1 R. For these ligands, a temperature-dependent selectivity switch between hH 1 R and gpH 1 R was observed. At 283.15 K, ligands 5 to 7 exhibited higher affinity to hH 1 R than to gpH 1 R, but at 303.15 K (for 6 and 7) and 308.15 K (for 5), the ligands exhibited higher affinity to gpH 1 R than to hH 1 R. This was most pronounced for amitriptyline 5 (Fig. 4) . At temperatures below 295 K, amitriptyline 5 showed higher affinity at hH 1 R than at gpH 1 R; at a temperature of approximately 295 K, there were no differences in affinity between hH 1 R and gpH 1 R. At temperatures above 295 K, however, amitriptyline 5 showed higher affinity at gpH 1 R than at hH 1 R.
The affinities of histamine, phenylhistamines, histaprodifens, and chiraprodifens were in a pK i range from approximately 4 to 7. In general, these ligands 10 to 22 showed no temperature-dependence in affinity or increasing affinity with increasing temperature, except for histamine 9. The affinity of histamine 9 decreased slightly with increasing temperature (Fig. 2) . For the ligands 9 to 11, 13 to 18, and 21R, no species differences between hH 1 R and gpH 1 R at the different temperatures were found. Nonetheless, there were species differences at several temperatures for compounds 12, 19, 20, 21S, and 22. These species differences were not significantly temperature dependent.
Ligand-and Receptor-Specific Differences in Thermodynamic Parameters of Ligand Binding. All thermodynamic parameters were calculated with Prism using eq. 11 and are given in Table 2 . Enthalpy ranged from approximately Ϫ35 to 80 kJ/mol at hH 1 R and from approximately Ϫ25 to 100 kJ/mol at gpH 1 R. Entropy ranged from approximately Ϫ20 to 410 J/K mol Ϫ1 at hH 1 R and from approximately 20 to 500 J/K mol Ϫ1 at gpH 1 R. The data show that the enthalpy for formation of the ligand-receptor complex at gpH 1 R is nearly equal or up to 40 kJ/mol higher than at hH 1 R. In addition, the entropy for formation of the ligandreceptor complex at gpH 1 R was nearly equal or up to 135 J/K mol Ϫ1 higher than at hH 1 R. This implies that ϪT⌬S°at gpH 1 R is nearly equal or up to Ϫ40 kJ/mol smaller than at hH 1 R at a temperature of 293.15 K. A correlation between ⌬H°and ϪT⌬S° (Fig. 5) shows that, in general, the formation of the ligand-receptor complex is entropy-driven at hH 1 R and gpH 1 R. It is noteworthy that, at hH 1 R, the formation of some ligand-receptor complexes was not only entropy-driven but also slightly enthalpy-driven. A completely different behavior with regard to the mentioned trend was observed for histamine 9. At hH 1 R and gpH 1 R, the formation of the histamine-receptor complex is enthalpy-driven but not or only slightly entropy-driven at a temperature of 293.15 K. Thus, only for the endogenous ligand histamine 9 is the formation of the ligand-receptor complex significantly enthalpy-driven at 293.15 K. As Fig. 5 shows, for hH 1 R and gpH 1 R, it is not possible to discriminate between agonism and antagonism based on thermodynamical data. The antagonists fexofenadine 3, terfenadine 4, mianserine 6, and clozapine 7 showed very high ⌬H°(p,T o ) and ⌬S°(p,T o ) at hH 1 R and gpH 1 R, outside the region in which most of the ligands located. This may be explained with specific solvent effects for 3 and 4 or the ligand rigidity for 6 and 7.
As shown in Table 2 , ⌬C p°-values ranged between Ϫ5 and 5 kJ/mol K Ϫ1 and are different from zero for some ligandreceptor systems. Consequently, the enthalpy and entropy of formation of the ligand-receptor complex is temperature-dependent for these systems (e.g., for the formation of the dimeric histaprodifen 22-gpH 1 R receptor complex). If ⌬C p°i s zero, ⌬H°and ⌬S°are independent of temperature, resulting in a linear temperature dependence for ⌬G°. However, as can be seen in Fig. 6 , ⌬G°was not linearly dependent on temperature for dimeric histaprodifen 22 at gpH 1 R, indicating a ⌬C p°d ifferent from zero. However, it should be noted that for many compounds, the errors in ⌬C p°v alues are in the same range as the ⌬C p°v alues themselves. This is a consequence of Cheng and Prusoff (1973) . Data shown are the means Ϯ S.E.M. of at least two to four experiments with independent membrane preparations in duplicates each. 3 H]mepyramine as described under Materials and Methods. Data were analyzed by nonlinear regression and were best fit to one-site (monophasic) competition curves. pK i values were calculated according to Cheng and Prusoff (1973) . Data shown are the means Ϯ S.E.M. of at least two to four experiments with independent membrane preparations in duplicates each. a nonattainable precision in measurement of pK i values. Nonetheless, we used eq. 11 for data analysis because the van't Hoff equation is only a special case of eq. 11. Given this, the data summarized in Table 2 show the trend that ⌬C p°c ould be higher at gpH 1 R, than at hH 1 R. Hence, it may be concluded that either enthalpy or entropy of the free gpH 1 R or gpH 1 R-ligand complex are more temperature-dependent than the corresponding parameters at hH 1 R. For the D 2 receptor, temperature dependence of binding enthalpy and entropy (Kilpatrick et al., 1986; Duarte et al., 1988) was described for some cases. At the D 2 receptor, ⌬C p°v alues range between Ϫ3 and 3 kJ/mol K Ϫ1 . A similar phenomenon was also described for the A 1 receptor (Borea et al., 1992; Casado et al., 1993 ) with values ⌬C p°o f approximately Ϫ10 and 10 kJ/mol at 293.15 K. Thus, it can be concluded that the heat capacity ⌬C p°s hould be included into the thermodynamic analysis of ligand-receptor binding in general.
We also calculated ⌬H°and ϪT⌬S°at 283.15, 288.15, 298.15, and 303.15 K. In the temperature range from 283.15 to 303.15 K, for some ligands, the formation of the ligandreceptor complex switched from enthalpy-driven to entropydriven and vice versa. For histamine 9, this switch was species-dependent (Fig. 7) .
3D-QSAR. On the one hand, The 3D-QSAR calculations were performed to predict the pK i values of different orientations. On the other hand, the thermodynamic properties of the ligands should be predicted, especially the contribution of orientations 1 and 2 onto the thermodynamic properties. The alignment of the ligands docked in gpH 1 R is shown in Fig. 8 . For each 3D-QSAR analysis, the standard error of estimate was smaller than 0.05 in pK i ; r 2 was larger than 0.997 in all 3D-QSAR calculations. The predicted pK i values for compounds 19 to 21 for orientations 1 and 2 are given in Table 3 at each temperature. Considering the pK i values for orientations 1 and 2, the effective pK i values are calculated without any implications about the contribution of orientation 1 or 2. The comparison of predicted, effective pK i values with the experimental data shows deviations smaller than approximately 0.6 in pK i .
The predicted thermodynamic parameters for compounds 19, 20, 21R, and 21S for each orientation are given in Table  4 . The prediction of the effective values, including orientations 1 and 2, based on the predicted pK i values corresponds well to the experimental data for ⌬H°(p,T o ), ⌬S°(p,T o ), and ⌬G°(p,T o ). The prediction of ⌬C p°i s not as good as for the other thermodynamic data but is in range of the experimental errors.
Species Differences in Enthalpy and Entropy of the Ligand-Receptor Binding Process. At the reference temperature of 293.15 K, we observed, in general, the trend that ⌬H°(p,T o ) at gpH 1 R is equal or higher than at hH 1 R. In contrast, ϪT⌬S°(p,T o ) at gpH 1 R is equal or smaller than at gpH 1 R. Consequently, we conclude that the loss in enthalpy at gpH 1 R compared with hH 1 R is compensated for by an increase in entropy. These species differences are liganddependent and are illustrated in Fig. 9 . The data shown in Fig. 9 correspond to the equations ( 12) and
Thus, these data include the differences in enthalpies or entropies of ligand-receptor complexes and the free receptors 4 . Temperature-dependence of pK i and ⌬G°(p,T) for amitriptyline 5 at hH 1 R and gpH 1 R. a, temperature-dependence of pK i values for amitriptyline 5 at hH 1 R and gpH 1 R, based on the data given in Table 2 . b, temperature-dependence of ⌬G°(p,T) values for amitriptyline 5 at hH 1 R and gpH 1 R; the data were calculated using eq. 2 as described under Materials and Methods.
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at ASPET Journals on April 13, 2017 molpharm.aspetjournals.org for hH 1 R and gpH 1 R but not enthalpies or entropies for the free ligand. Therefore, the quantities ⌬⌬H°(p,T o ) gpϪh and ϪT o ⌬⌬S°(p,T o ) gpϪh are ligand-independent but, relative to each other, dependent on the ligand-receptor-complex. For mianserin 6, the largest species difference is observed (Fig. 9, group I) . In the next group (Fig. 9, group II) are the tricyclic compounds amitriptyline 5, clozapine 7, and chlorpromazine 8, as well as the histaprodifens, which can bind in two different orientations into the binding pocket, such as suprahistaprodifen 19, phenoprodifen 20, and the chiral phenoprodifens 21R and 21S. In group III (Fig. 9) , ligands with enthalpic species differences in a range from Ϫ9 to Ϫ16 kJ/mol, and entropic species differences in a range from Ϫ9 to Ϫ19 kJ/mol are found. These ligands include histamine 9, phenylhistamine 10, dimeric phenylhistamine 11, histaprodifen 13, and the histaprodifen derivatives 15 to 17 and 22. The last group (Fig. 9, group IV) , with smaller enthalpic and entropic species differences in a range from Ϫ5 to 5 kJ/mol, comprises the flexible antagonists 1 to 4, the chiral phenylhistamines 11R and 11S, and the histaprodifen derivatives 14 and 18. The location of the effective enthalpic and entropic species differences between hH 1 R and gpH 1 R for 19, 20, 21R, Table 2 . Region H, enthalpy-driven; Region S, entropydriven; Region H and S, enthalpy-and entropy-driven. Fig. 6 . Temperature-dependence of ⌬G°(p,T) for dimeric histaprodifen 22 at hH 1 R and gpH 1 R. ⌬G°values at the different temperatures were calculated using eq. 2 as described under Materials and Methods, based on the data given in Table 1 . Fig. 7 . ⌬H°(p,T) and ϪT⌬S°(p,T) as a function of temperature for histamine 9 at hH 1 R and gpH 1 R. The quantities ⌬H°(p,T) and ϪT⌬S°(p,T) were calculated based on the data in Table 2 , using the equation and 21S far away from the other phenylhistamines and histaprodifens is a priori unexpected. However the 3D-QSAR prediction with regard to enthalpy and entropy of these ligands for orientations 1 and 2 shows a shift away from the nonflexible antagonists (group II) toward phenylhistamines and histaprodifens (Fig. 9). For 19, 20, 21R , and 21S, orientation 1 is found in the same group (group III) as histaprodifen and most histaprodifen derivatives. In contrast, for 19 and 20, orientation 2 is found in the same range (group III) as histamine 9 and phenylhistamine 10, but for 21R and 21S orientation 2 is found in the same range (group IV) as the chiral phenylhistamines 11R and 11S, respectively.
The separation of the effective ⌬⌬H°(p,T o ) gpϪh and ϪT⌬⌬S°(p,T o ) gpϪh into the predicted data for orientation 1 and 2 (Fig. 9) shows, that for 19, 20, 21R , and 21S the quantities for orientation 1 are found in group III. In orientation 1, the histaprodifen moieties of 19, 20, 21R, and 21S are located in the same part of the binding-pocket as histaprodifen 13 itself. In group III, 13 and dimeric histaprodifen 22 are found too. In contrast, for 19, 20, 21R, and 21S, the quantities for orientation 2 are found in group III only for 19 and 20 but in group IV for 21R and 21S. In orientation 2, the histaprodifen moieties of 19, 20, 21R, and 21S are located not in the histaprodifen binding-pocket itself, but in a pocket possessed by the second histaprodifen moiety of 22, located near TM2. The histamine moiety of 19 and phenylhistamine moieties of 20, 21R, and 21S in orientation 2 are located in the binding-pocket of histamine 9 and phenylhistamines 10, 11R, and 11S itself. Compounds 9 and 10 are located in group III, as well as orientation 2 of compounds 19 and 20. In addition, the chiral phenylhistamines 11R and 11S belong to group IV, as well as orientation 2 of compounds 21R and 21S. Furthermore, the data suggest that there is no change in species difference of ⌬⌬H°(p,T o ) gpϪh and ϪT⌬⌬S°(p,T o ) gpϪh in case of introduction of a second phenylhistamine moiety into 10, resulting in 12, or in the case of introduction of a second histaprodifen moiety into 13, resulting in 22. Based on these data we suggest that the part of the entire bindingpocket of phenylhistamine 10 and histaprodifen 13, located near to TM5 is responsible for the membership of 19, 20, 21R, and 21S (Strasser et al., 2009 ) dependent from orientation to group III or group IV.
Discussion
Thermodynamic Discrimination between Antagonism and Agonism. Previous studies showed that it is possible to discriminate between agonism and antagonism based on binding enthalpy and binding entropy for some GPCRs. Discrimination was found for the ␤-adrenergic receptor and the A 1 and A 2A receptors. The formation of ligand-receptorcomplexes is enthalpy-driven for agonists and enthalpy-and The calculations were performed as described under Materials and Methods. ⌬ describes the difference pK i (predicted) Ϫ pK i (experimental). The effective pK i value (eff), including orientation 1 (or1) and orientation 2 (or2) was calculated using equation log 10 (K i (or1) ϩ K i (or2)) as described previously (Strasser et al., 2009 entropy-driven for antagonists at ␤-adrenergic receptor (Weiland et al., 1979; Contreras et al., 1986a,b) . In contrast, the formation of ligand-receptor-complexes is entropy-driven for agonists and enthalpy-and entropy-driven for antagonists at A 1 receptors and A 2A receptors. For the D 2 (Duarte et al., 1988) and 5-HT 1A receptor , discrimination between agonism and antagonism based on ⌬H°and ⌬S°is not possible. A study on the H 3 receptor (Harper and Black, 2007a) showed that discrimination between agonism and antagonism depends of the experimentally used buffer. ⌬H°is found in a range from approximately Ϫ225 to 100 kJ/mol, ⌬S°is in a range from The thermodynamic parameters are calculated based on the predicted pK i values (Table 3) as described under Materials and Methods. The difference predicted quantity-experimental quantity for the effective quantities is given by ⌬.
Compound, H 1 R Species, Orientation approximately Ϫ600 to approximately 450 J/mol/K for GPCRs (Borea et al., 2000) . To our knowledge, we are the first to study the binding thermodynamics of the H 1 -receptor, including H 1 R antagonists and agonists with large structural differences. At 293.15 K, ⌬H°(p,T o ) ranges from approximately Ϫ40 to approximately 90 kJ/mol, and ⌬S°(p,T o ) ranges from approximately Ϫ20 to approximately 500 J/mol/K. These findings for the H 1 R are in very good accordance with the findings for other GPCRs. The correlation between ⌬H°(p,T o ) and ϪT⌬S°(p,T o ) for hH 1 R and gpH 1 R (Fig. 5) shows that discrimination between agonism and antagonism based on binding enthalpy and entropy is not possible for hH 1 R and gpH 1 R. Thus, the H 1 R is more related to the D 2 and 5-HT 1A receptors than to ␤-adrenergic or adenosine receptors, concerning thermodynamic discrimination between agonism and antagonism. To obtain a more detailed insight in thermodynamic agonist-antagonist discrimination, even more compounds with high structural diversity have to be studied at several GPCRs.
For the process of ligand-binding to a receptor including receptor activation in case of agonists several subprocesses have to be considered: 1) Disruption of ligand-solvent-complex, 2) formation of ligand-receptor-complex, 3) conformational change of the ligand, 4) disruption of hydrogen-bonds in the receptor and formation of new hydrogen-bonds and, 5) change in receptor conformation. Thus, the energetic contribution of these subprocesses leads to the effective change in binding free energy, binding enthalpy, and binding entropy, which can be determined experimentally. Because of the complexity of this process, we propose that dependent on ligand structure but independent of agonistic or antagonistic function of the ligand, some of the subprocesses (i.e., 1 to 5) energetically cancel each other out or intensify each other. Thus, for a thermodynamic study of ligand-receptor interactions, a broad structural variety within the agonists and antagonists has to be guaranteed. Because changes in heat capacity for formation of ligand-receptor processes different from zero were observed, it should also be taken into account that an entropy-driven binding process can change to an enthalpy-driven binding process and vice versa with increasing temperature. Thus, the discrimination between agonism and antagonism may be a function of temperature.
Thermodynamic Measurements-A New Approach for the Dissection of Ligand-Specific Receptor Conformations? A number of experimental data based on fluorescence spectroscopy (Ghanouni et al., 2001 ) suggest the existence of agonist-dependent receptor conformations. Within the series of analyzed compounds in this study, our data suggest that the endogenous ligand histamine stabilizes the ligand-receptor-complex enthalpically, in contrast to the other analyzed agonists, where no enthalpic stabilization is observed (Fig. 5) . Further studies including more natural or synthetic compounds have to be carried out to improve our knowledge about compounds being enthalpically favored in binding to the H 1 R. One reason for the different behavior of histamine in contrast to phenylhistamines and histaprodifens concerning the enthalpy may be the different binding mode of histamine compared with those of phenylhistamines and histaprodifens (Fig. 8) . It was shown experimentally that Lys 5.39 forms a hydrogen bond to the imidazole moiety of histamine . In contrast, further experimental data show that an interaction between Lys 5.39 and histaprodifens is not established . In addition, Gln 5.46 interacts with histamine but not with phenylhistamine (Leurs et al., 1994) . If there is a compensation of the loss of enthalpy of solvation of histamine by a benefit of enthalpy of histamine-receptor interaction, the data suggest a receptor conformation specifically stabilized by histamine. In addition, it has to be considered that histamine, acting as full agonist, should promote a change of receptor conformation from inactive to active state. Thus, it may be speculated, that ⌬H°(p,T o ) mainly includes the enthalpy related to changes in receptor conformation. These results are in good accordance with the description of agonist-dependent receptor conformations (Xie et al., 2006; Kobilka and Deupi, 2007) .
The data (Fig. 9) suggest that the species differences in ⌬⌬H°(p,T o ) gp-h and ⌬⌬S°(p,T o ) gp-h are closely related to flexibility of the ligand and of the receptor. Antagonist 6 is very rigid and belongs to group I, which has the largest species differences. Antagonists 5, 7, and 8 belong to group II, which has smaller species differences, and have a rigid, tricyclic moiety, but there are flexible side chains. For the highly flexible antagonists 1 to 4, belonging to group IV, no significant species differences are found. The flexible antagonists are able to undergo conformational changes to fit optimally into the binding pocket and to establish ligand-receptor interactions. Thus, these antagonists should be able to compensate for differences in receptor-flexibility between hH 1 R and gpH 1 R, which is not possible for the rigid antagonists. Because ⌬H°(p,T o ) is significantly higher at gpH 1 R than at hH 1 R for the rigid antagonists, it can be supposed that hH 1 R is more flexible than gpH 1 R, resulting in a better ligandreceptor interaction at hH 1 R. In addition, it should be considered, that it is proposed that antagonists do not induce a change of the receptor conformation from the inactive state to the active state. Thus, only the loss of enthalpy of solvation of the ligand and the benefit of ligand-receptor interactions should contribute to ⌬H°(p,T o ). Because there are no differences in amino acids, interacting with antagonists in the binding pocket, between hH 1 R and gpH 1 R, there should be no differences in binding enthalpies between hH 1 R and gpH 1 R. This was observed for the flexible antagonists. Because of their flexibility, they can undergo conformational changes to fit optimally into the binding pocket of hH 1 R and gpH 1 R. Thus, there is no need for the receptor to change its conformation. In contrast, we observed species differences in binding enthalpy between hH 1 R and gpH 1 R in the range of approximately 25 to 40 kJ/mol for the rigid antagonists. Because there are no obvious differences in the binding pocket between hH 1 R and gpH 1 R, this result is surprising. Thus, these results may be explained by differences in flexibility of the receptor or compactness of the receptor structure caused by changes of H-bonding network of the receptor as a result of the differences in amino acid sequences between hH 1 R and gpH 1 R (Strasser et al., 2008b) , especially concerning N terminus and E2-loop. Another possible explanation for the observed species differences of the rigid antagonists may be antagonist-dependent receptor conformations in the inactive state. Our data, based on thermodynamic measurements, suggest that different receptor conformations exist not only for the active state but also for the inactive state of the receptor. The species differences observed for the flexible agonists may be explained in contrast to the antagonists, not with flexibility of the ligands but with species-dependent conformational changes of the receptor, because of its activation by the agonists. The division of the agonists in two groups (Fig. 9 ) may indicate that there exist agonist-dependent receptor conformations.
Conclusions
In our study, we have analyzed the binding of a large variety of antagonists and agonists to the hH 1 R and gpH 1 R thermodynamically. Our data suggest species differences between hH 1 R and gpH 1 R are observed not only in affinity but also in ⌬H°(p,T) and ⌬S°(p,T). In addition, our study shows that, in contrast to some other GPCRs, antagonists and agonists cannot be distinguished thermodynamically for the H 1 R. But our data may suggest that there are different conformations not only of the active state of the receptor but also of the inactive state for the H 1 R.
